PB1966: THE EFFECT OF BODY MASS INDEX ON THE SAFETY OF BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A POST HOC POOLED DATA ANALYSIS

por Isfort, Susanne, Gambacorti-Passerini, Carlo, Brümmendorf, Tim H, Smith, B. Douglas, Purcell, Simon, Zhao, Huadong, Kuttschreuter, Luke, Apperley, Jane
Publicado 2023

P676: UPDATED RESULTS FROM THE TRIAL ITCC-054/COG-AAML1921: BOSUTINIB IN NEWLY DIAGNOSED AND RESISTANT/INTOLERANT PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA

por Brivio, Erica, Pennesi, Edoardo, Willemse, Marieke, Jiang, Yilin, van der Velden, Vincent, Beverloo, Berna, Hudson, Chad, Kuttschreuter, Luke, van der Sluis, Inge, Brethon, Benoît, Bautista, Francisco, J. Burke, Michael, Heerema, Nyla, Bukowinski, Andrew, Cooper, Stacy, Pollard, Jessica, Nagasubramani, Ramamoorthy, Redell, Michele, Bourquin, Jean-Pierre, Pais, Ray, Frediani, Jamie, Batra, Sandeep, Bertorello, Nicoletta, Boklan, Jessica, Kheradpour, Albert, Kyono, Wade, Kowalski, Karey, Mizukawa, Benjamin, Lancaster, Donna, Murillo-Sanjuán, Laura, Krystal, Julie, Bertrand, Yves, Huitema, Alwin, van Tinteren, Harm, Locatelli, Franco, Roth, Michael, Hijiya, Nobuko, Zwaan, Michel
Publicado 2023